Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review

BACKGROUND: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are a relatively novel class of oral medications for the treatment of Type 2 DM with a generally acceptable safety profile. However, these agents have been associated with rare events of a serious and potentially life-threatening compli...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampani, Erasmia, Sarafidis, Pantelis, Dimitriadis, Chrysostomos, Kasimatis, Efstratios, Daikidou, Dimitra, Bantis, Konstantinos, Papanikolaou, Alexios, Papagianni, Aikaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364613/
https://www.ncbi.nlm.nih.gov/pubmed/32669085
http://dx.doi.org/10.1186/s12882-020-01930-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364613/
https://www.ncbi.nlm.nih.gov/pubmed/32669085
http://dx.doi.org/10.1186/s12882-020-01930-6

Ejemplares similares